echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > Win Innovative Methionine Integrated Plant Goes Into Production in Singapore

    Win Innovative Methionine Integrated Plant Goes Into Production in Singapore

    • Last Update: 2020-06-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Evonik's global methionine production capacity increased to 580,000 metric tonsUeAthe first world-class methionine plant located in the fast-growing Asian market
    UeAEvonik's largest single investment project to date, with a total investment of more than 500 million eurosUeA, which took two years to build, and Evonik Industries' new methionine integrated plant in Singapore was officially launched on November 4, 2014The new plant has an annual production capacity of 150,000 metric tons, which increases the world's annual production capacity of methionine to 580,000 metric tons"With the completion of Asia's first and most modern world-class methionine plant, we are continuing to expand the company's leading market and technology leadership in The DL-Methanine," Evonik Industrial Group Chairman Inkaishi said at a launch ceremony in SingaporeEvonik sells DL-methine products under the MetAMINO ® brandUeA
    With an investment of more than 500 million euros, this integrated plant is by far the largest single investment project in Evonik"Methionine is one of our core businesses, and Asia is the fastest growing methionine market in the world, so we decided to build a plant here," explains InkaiHe thanked government representatives and customers who attended the launch ceremony for their strong support for the projectUeA
      The new methionine integrated plant will produce MetAMINO ® and all strategically important precursor products "Thanks to our localization strategy, the integrated equipment of the new plant, and the global production network of MetAMINO ® products, we are able to provide maximum supply assurance to our customers in Asia." The new plant is close to some of our key markets, such as China, and it enables us to respond quickly to local needs, develop innovative market-oriented products, and further expand our presence in those markets," said Dr Reiner Beste, Head of Evonik Health and Nutrition UeA
      Advances in feed technology, rapid population growth and growing meat consumption are driving the huge demand for methionine in Asian markets UeA
      Investing in high-growth amino acid specialty products UeA feed additive MetAMINO ® ensure that poultry and pigs receive more balanced nutrition and protect resources and the environment, thus making a valuable contribution to the sustainable development of food production UeA
      In addition, Evonik is investing in high-growth amino acid specialty products At present, the company is building different methionine formula requirements of new product symn factories, suitable for other animal breeding Alabama, for example, will have a new plant to produce the Mepron ® for cow feeding Mepron ® has special packets that prevent amino aciddegradation in the stomach For aquaculture, such as shrimp and other crustaceans, Evonik developed aquaVI ® Met-Met product, a dipeptide consisting of two methionine molecules The first plant of the product is being built in Antwerp, Belgium UeA
      Evonik is the only company in the world that produces and sells four amino acids essential for modern animal feed, including: MetAMINO ® (DL-methionine), Mepron ® (DL-methine for ruminants), DL-methine (for AquacultureTM), Biolys ® (L-Lysine Raw material), Threamino ® (L-Sumine) and ® As a solution provider, Evonik also provides customers with comprehensive professional advice and customized services, and has a global sales network of amino acid products UeA
      Company Information UeA Evonik is an innovative industrial group from Germany, our core business - specialty chemicals in the world leader Improving business profitability and maintaining continued growth in corporate value are the core strategies of Evonik We combine business with global trends, namely health, nutrition, resource efficiency, globalization Evonik's development benefits from its innovative strength and integrated technology platform Evonik operates in more than 100 countries around the world In fy2013, Evonik generated sales of approximately EUR 12.7 billion and operating profit (EBITDA) of EUR 2 billion UeA
      Evonik Has been producing specialty chemicals in Greater China since the late 1970s, including Chinese mainland, Hong Kong and Taiwan, and has extensive operations in the region since before Evonik Greater China is one of the driving forces for global economic growth and is constantly striving to achieve continued growth in greater China Evonik Greater China now employs approximately 3,200 people and generated sales of more than 1 billion euros in 2013 UeA
      Disclaimer UeA , as of present, the forecasts or expectations made in these press releases or any future forward-looking statements may contain certain known or unknown risks and uncertainties As the company's business environment changes, the actual development results may not be the same as expected Evonik Industries group and its Group companies are not obliged to update any forecasts, expectations or statements made in this press release UeA Evonik's global methionine production capacity increased to 580,000 metric tons UeA the first world-class methionine plant located in the fast-growing Asian market
    UeA Evonik's largest single investment project to date, with an investment of more than 500 million euros UeA over a two-year construction period, and Evonik Industrial Group's new methionine integration plant in Singapore was officially launched on November 4, 2014 The new plant has an annual production capacity of 150,000 metric tons, which increases the world's annual production capacity of methionine to 580,000 metric tons "With the completion of Asia's first and most modern world-class methionine plant, we are continuing to expand the company's leading market and technology leadership in The DL-Methanine," Evonik Industrial Group Chairman Inkaishi said at a launch ceremony in Singapore Evonik sells DL-methine products under the MetAMINO ® brand UeA
      With an investment of more than 500 million euros, this integrated plant is by far the largest single investment project in Evonik "Methionine is one of our core businesses, and Asia is the fastest growing methionine market in the world, so we decided to build a plant here," explains Inkai He thanked government representatives and customers who attended the launch ceremony for their strong support for the project UeA
      The new methionine integrated plant will produce MetAMINO ® and all strategically important precursor products "Thanks to our localization strategy, the integrated equipment of the new plant, and the global production network of MetAMINO ® products, we are able to provide maximum supply assurance to our customers in Asia." The new plant is close to some of our key markets, such as China, and it enables us to respond quickly to local needs, develop innovative market-oriented products, and further expand our presence in those markets," said Dr Reiner Beste, Head of Evonik Health and Nutrition UeA
      Advances in feed technology, rapid population growth and growing meat consumption are driving the huge demand for methionine in Asian markets UeA
      Investing in high-growth amino acid specialty products UeA feed additive MetAMINO ® ensure that poultry and pigs receive more balanced nutrition and protect resources and the environment, thus making a valuable contribution to the sustainable development of food production UeA
      In addition, Evonik is investing in high-growth amino acid specialty products At present, the company is building different methionine formula requirements of new product symn factories, suitable for other animal breeding Alabama, for example, will have a new plant to produce the Mepron ® for cow feeding Mepron ® has special packets that prevent amino aciddegradation in the stomach For aquaculture, such as shrimp and other crustaceans, Evonik developed aquaVI ® Met-Met product, a dipeptide consisting of two methionine molecules The first plant of the product is being built in Antwerp, Belgium UeA
      Evonik is the only company in the world that produces and sells four amino acids essential for modern animal feed, including: MetAMINO ® (DL-methionine), Mepron ® (DL-methine for ruminants), DL-methine (for AquacultureTM), Biolys ® (L-Lysine Raw material), Threamino ® (L-Sumine) and ® As a solution provider, Evonik also provides customers with comprehensive professional advice and customized services, and has a global sales network of amino acid products UeA
      Company Information UeA Evonik is an innovative industrial group from Germany, our core business - specialty chemicals in the world leader Improving business profitability and maintaining continued growth in corporate value are the core strategies of Evonik We combine business with global trends, namely health, nutrition, resource efficiency, globalization Evonik's development benefits from its innovative strength and integrated technology platform Evonik operates in more than 100 countries around the world In fy2013, Evonik generated sales of approximately EUR 12.7 billion and operating profit (EBITDA) of EUR 2 billion UeA
      Evonik Has been producing specialty chemicals in Greater China since the late 1970s, including Chinese mainland, Hong Kong and Taiwan, and has extensive operations in the region since before Evonik Greater China is one of the driving forces for global economic growth and is constantly striving to achieve continued growth in greater China Evonik Greater China now employs approximately 3,200 people and generated sales of more than 1 billion euros in 2013 UeA
      Disclaimer UeA , as of present, the forecasts or expectations made in these press releases or any future forward-looking statements may contain certain known or unknown risks and uncertainties As the company's business environment changes, the actual development results may not be the same as expected Evonik Industries group and its Group companies are not obliged to update any forecasts, expectations or statements made in this press release UeA
    Share it on feed
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.